aod9604 fat loss clinical trials efficacy side effects AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's effects. The clinical question AOD-9604 (10mg vials) - Peptide

I have lived an active life

In clinical trials, AOD9604 was shown to reduce abdominal fat mass in overweight individuals without affecting lean mass or glucose levels. Ng et al., Obesity Research & Clinical Practice 2

Combined use of retatrutide and 5-Amino-1MQ should not occur outside the context of an ethically approved clinical trial

If a customer does not routinely monitor their email and would prefer a phone call, they must let us know when placing an order

Unlike full-length growth hormone, AOD-9604 does not upregulate IGF-1, does not induce insulin resistance in reported toxicology models, and does not measurably affect linear growth in adult animal models